Nutex Health Inc (NASDAQ:NUTX) shares, rose in value, with the stock price down by -7.16% to the previous day’s close as strong demand from buyers drove the stock to $0.09.
Actively observing the price movement in the last trading, the stock closed the session at $0.09. Referring to stock’s 52-week performance, its high was $1.10, and the low was $0.09. On the whole, NUTX has fluctuated by -23.70% over the past month.
With the market capitalization of Nutex Health Inc currently standing at about $64.76 million, investors are eagerly awaiting this quarter’s results, scheduled for May 13, 2024 – May 17, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0, which is expected to increase to $0 for fiscal year -$0.01 and then to about $0 by fiscal year 2025.
Analysts have estimated the company’s revenue for the quarter at $70.3 million, with a low estimate of $70.3 million and a high estimate of $70.3 million. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $316.2 million, representing an increase of 27.70% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that NUTX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of NUTX currently trading nearly -14.16% and -23.38% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 25.89, while the 7-day volatility ratio is showing 6.58% which for the 30-day chart, stands at 8.40%. Furthermore, Nutex Health Inc (NUTX)’s beta value is 0.11, and its average true range (ATR) is 0.01.
A comparison of Nutex Health Inc (NUTX) with its peers suggests the former has fared considerably weaker in the market. NUTX showed an intraday change of -7.16% in last session, and over the past year, it shrunk by -91.40%%.
Data on historical trading for Nutex Health Inc (NASDAQ:NUTX) indicates that the trading volumes over the past 10 days have averaged 1.26 million and over the past 3 months, they’ve averaged 1.80 million. According to company’s latest data on outstanding shares, there are 676.68 million shares outstanding.
Nearly 41.51% of Nutex Health Inc’s shares belong to company insiders and institutional investors own 4.79% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.47 million shares as on Mar 15, 2024, resulting in a short ratio of 0.84. According to the data, the short interest in Nutex Health Inc (NUTX) stood at 0.20% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 2.5 million. The stock has fallen by -51.72% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the NUTX stock heading into the next quarter.
